We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$515M
AUM Growth
+$15.8M
Cap. Flow
+$4.8M
Cap. Flow %
0.93%
Top 10 Hldgs %
19.88%
Holding
127
New
2
Increased
93
Reduced
5
Closed
27

Top Buys

Rank Stock Value
1
NOVT icon
Novanta
NOVT
+$5.87M
2
PAY
Verifone Systems Inc
PAY
+$3.26M
3
CAMP
CalAmp Corp.
CAMP
+$2.03M
4
REI icon
Ring Energy
REI
+$1.67M
5
ASC icon
Ardmore Shipping
ASC
+$1.15M

Sector Composition

Rank Sector Weight
1 Industrials 20.07%
2 Technology 15.76%
3 Financials 14.21%
4 Healthcare 13.96%
5 Consumer Discretionary 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WNC icon
26
Wabash National
WNC
$504M
$6.71M 1.3%
528,351
-36,356
-6% -$489K
INWK
27
DELISTED
InnerWorkings, Inc.
INWK
$6.23M 1.21%
753,356
+22,763
+3% +$187K
MRCY icon
28
Mercury Systems
MRCY
$5.76B
$6.22M 1.21%
250,294
+8,110
+3% +$174K
EPAY
29
DELISTED
Bottomline Technologies Inc
EPAY
$6.15M 1.19%
285,469
+7,596
+3% +$199K
AER icon
30
AerCap
AER
$24.1B
$6.01M 1.17%
178,825
+5,715
+3% +$219K
PBH icon
31
Prestige Consumer Healthcare
PBH
$2.37B
$5.99M 1.16%
108,055
+3,524
+3% +$194K
CHE icon
32
Chemed
CHE
$7.1B
$5.91M 1.15%
43,361
+1,342
+3% +$178K
NOVT icon
33
Novanta
NOVT
$4.95B
$5.78M 1.12%
+381,748
New +$5.87M
KRA
34
DELISTED
Kraton Corporation
KRA
$5.7M 1.11%
204,012
+7,246
+4% +$177K
GAS
35
DELISTED
AGL Resources Inc
GAS
$5.69M 1.11%
86,282
+2,443
+3% +$161K
AEIS icon
36
Advanced Energy
AEIS
$11B
$5.61M 1.09%
147,842
+5,273
+4% +$189K
GWB
37
DELISTED
Great Western Bancorp, Inc.
GWB
$5.5M 1.07%
174,337
-128
-0.1% -$3.98K
B
38
DELISTED
Barnes Group Inc.
B
$5.48M 1.06%
165,452
+5,169
+3% +$176K
ITRI icon
39
Itron
ITRI
$4.33B
$5.42M 1.05%
125,673
+4,184
+3% +$177K
SP
40
DELISTED
SP Plus Corporation
SP
$5.34M 1.04%
236,508
+3,711
+2% +$83.3K
WWE
41
DELISTED
World Wrestling Entertainment
WWE
$5.26M 1.02%
285,896
+9,398
+3% +$163K
STAG icon
42
STAG Industrial
STAG
$7.43B
$5.22M 1.01%
219,109
+5,272
+2% +$112K
REI icon
43
Ring Energy
REI
$315M
$5.16M 1%
584,787
+223,366
+62% +$1.67M
OA
44
DELISTED
Orbital ATK, Inc.
OA
$5.07M 0.98%
59,497
+1,940
+3% +$169K
CCRN
45
DELISTED
Cross Country Healthcare
CCRN
$4.83M 0.94%
347,194
+12,438
+4% +$165K
WLY icon
46
John Wiley & Sons Class A
WLY
$2.66B
$4.79M 0.93%
91,871
+3,154
+4% +$159K
WAB icon
47
Wabtec
WAB
$49.4B
$4.77M 0.93%
67,974
+2,030
+3% +$158K
QDEL icon
48
QuidelOrtho
QDEL
$1.13B
$4.76M 0.92%
266,364
+8,338
+3% +$144K
OPB
49
DELISTED
Opus Bank Common Stock
OPB
$4.73M 0.92%
140,032
+17,712
+14% +$627K
IWM icon
50
iShares Russell 2000 ETF
IWM
$80.2B
$4.64M 0.9%
40,373
+1,075
+3% +$121K

Similar funds

Aristotle Capital Boston's Q2 2016 Portfolio in Review

As of Q2 2016, Aristotle Capital Boston held 127 positions worth $515M, up 3.2% from $499M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston's Q2 2016 filing shows 2 new, 93 increased, 5 reduced and 27 closed positions. Its largest new stake was Novanta: 381,748 shares worth $5.78M. The largest sale was JARDEN CORPORATION, an estimated $8.17M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Aristotle Capital Boston's largest Q2 2016 buy was Novanta: 381,748 shares worth $5.78M.
  • Aristotle Capital Boston added most to CalAmp Corp. in Q2 2016, an estimated $2.03M increase.
  • Aristotle Capital Boston's biggest Q2 2016 reduction was Amsurg Corp, cutting an estimated $1.15M.
  • Aristotle Capital Boston fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $8.17M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $515M portfolio in Q2 2016.
  • Aristotle Capital Boston opened 2 new positions and closed 27 in Q2 2016.
  • Aristotle Capital Boston's portfolio value rose 3.2% quarter-over-quarter to $515M.

Based on Aristotle Capital Boston's 13F filing for Q2 2016, filed 15 Aug 2016.